Director, Business Development - Toxicology & Safety Assessment of Biologics, Multispecifics & ADCs (Preclinical Studies)

Position: Director, Business Development - Toxicology & Safety Assessment of Biologics, Multispecifics & ADCs (Preclinical Studies)

Location: Home-based – United States Salary: $150,000 to $200,000

Pharmaron is a global CRO (Contract Research Organization) helping pharma and biotech companies bring new therapies to life. With over 25,000 employees worldwide across 23 locations in the US, UK, and China, we support drug discovery through to manufacturing with fully integrated, high-quality services.

We're proud of the impact we make. Just last year, we supported over 1,000 preclinical safety studies, helping our clients advance their drug candidates with confidence. Our teams work across small molecules, ADCs, biologics, and gene therapies, partnering with more than 3,000 global customers. To learn more, visit www.pharmaron.com.

About The Role

Are you a toxicologist or an in vivo scientist who enjoys connecting great science with real-world impact? This could be your next step.

We're looking for a scientifically minded Director of Business Development to join our U.S. team. This role is ideal for someone with previous experience in toxicology, safety pharmacology, or preclinical development of large molecules (Biologics, Multispecifics & ADCs).

The job involves interfacing with our internal scientists to shape proposals, ensure client expectations are realistic and achievable, and help translate complex safety assessment needs into tailored solutions. Your scientific insight will be key to building trust with clients and turning conversations into successful, long-term partnerships.

Regular travel across the region is required to find new clients and maintain relationships with existing clients and this role is suitable for using your preclinical knowledge in drug discovery to help advance client's pipelines.

Key Responsibilities

• Lead business development efforts primarily across the United States, identifying and securing new opportunities with biotech and pharma clients in the preclinical toxicology and safety assessment of Biologics, Multispecifics & ADCs
• Build and maintain strong interpersonal relationships with senior stakeholders and teams with a partnership mindset to build a strong client base to understand toxicity of Large Molecules.
• In partnership with our scientific team, ensure that the design, delivery, and interpretation of innovative and rigorous toxicology strategies will help clients predict, assess and mitigate target- and modality related safety risks.
• Apply in-depth knowledge of own function and broad industry awareness to differentiate Pharmaron from the competition
• Represent Pharmaron at key industry events, conferences, and client meetings.
• Maintain a robust pipeline of qualified opportunities and consistently meet or exceed revenue targets.
• Provide market insights and competitive intelligence to inform strategic planning.
  
  
  

Candidate Profile

• A PhD in toxicology, cell biology or pharmacology accompanied by at least 10 years of relevant professional experience in toxicity and safety assessment of large molecules.
• Demonstrates a proven understanding of end-to-end biologics drug development with a track record of delivering toxicology programs enabling filing of an IND.
• Strong understanding of the Biologics CRO landscape and non GLP safety studies.
• Ability to coordinate tasks across multiple projects and effective communication of complex scientific concepts enabling success in securing opportunities in a goal-focused fashion
• Willingness to travel at least 30% within the assigned territory to build a new client base and maintain existing relationships.
  

About Pharmaron

Pharmaron (Stock Code: 300759.SZ/3759.HK) is a premier R&D service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and CGT products. With over 19,000 employees, and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan and China.

Pharmaron is proud to be an Equal Employment Opportunity and Affirmative Action employer.